Hangzhou Alltest Biotech Co., Ltd. (SHA:688606)
China · Delayed Price · Currency is CNY 65.91
+0.29 (0.44%)
At close: Mar 6, 2026
Hangzhou Alltest Biotech Market Cap
Hangzhou Alltest Biotech has a market cap or net worth of 5.16 billion as of March 6, 2026. Its market cap has decreased by -5.99% in one year.
Market Cap
5.16B
Enterprise Value
2.71B
Revenue
911.30M
Ranking
n/a
PE Ratio
23.97
Stock Price
65.91
Market Cap Chart
Since March 25, 2021, Hangzhou Alltest Biotech's market cap has decreased from 9.38B to 5.16B, a decrease of -44.95%. That is a compound annual growth rate of -11.36%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 5.16B | 3.16% |
| Dec 31, 2025 | 5.00B | 1.91% |
| Dec 31, 2024 | 4.91B | -8.43% |
| Dec 29, 2023 | 5.36B | -2.86% |
| Dec 30, 2022 | 5.52B | -16.76% |
| Dec 31, 2021 | 6.63B | -29.28% |
| Mar 25, 2021 | 9.38B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BMC Medical | 6.54B |
| Blue Sail Medical | 6.51B |
| Allmed Medical Products Co.,Ltd | 6.42B |
| QITIAN Technology Group | 6.08B |
| Zhonghong Pulin Medical Products | 5.32B |
| Jiangxi Sanxin Medtec | 5.03B |
| SWS Hemodialysis Care | 4.94B |
| Qingdao NovelBeam Technology | 4.82B |